Daily clinical lab news - Labmedica.com

Download Mobile App

Events

more events

14 Oct 2026 - 16 Oct 2026

JFBM 2026 – Journées Francophones de Biologie Médicale

15 Oct 2026 - 18 Oct 2026

12th Congress of the Croatian Society of Medical Biochemistry and Laboratory Medicine

20 Oct 2026 - 24 Oct 2026

ASHG 2026 Annual Meeting of the American Society of Human Genetics

Partner Sites

HospiMedica

AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies

Deep Brain Stimulation Window May Matter for Parkinson’s Patients With GBA1 Variants

Minimally Invasive Ultrasound-Guided Procedure Eases Carpal Tunnel Symptoms

FDA-Approved App Enables Pulmonary Pressure Monitoring and Medication Guidance in Heart Failure

Matrix-Based Skin Substitute Improves Closure of Diabetic Foot Ulcers

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

A blood-based marker detects Alzheimer’s-related brain changes decades before symptoms appear in people with Down syndrome.
Read more
08 Oct 2026

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

08 Oct 2026

Single-Tier Lyme Disease Test Shows High Sensitivity in Early Infection

08 Oct 2026

Study Questions Broad Fasting Requirements Before Routine Blood Tests

08 Oct 2026

New NGS Suite Expands Clonality and MRD Research in Lymphoid Malignancies

08 Oct 2026

Tumor-Informed ctDNA Test Shows Utility Across Gastrointestinal and Gynecologic Cancers

08 Oct 2026

Visit expo >

Platinum Member

Automated Coagulation Analyzer

Hemolumi H6

Gold Member

Neonatal Heel Incision Device

Tenderfoot

New

Nucleic Acid Purification Instrument

QIAsymphony Connect

Automatic CLIA Analyzer

Shine i6000

In Other News

Image: The study was carried out by Start4All, a partnership led by Liverpool School of Tropical Medicine (LSTM) with the Stop TB Partnership and research partners in seven countries with a high TB burden (Photo courtesy of Liverpool School of Tropical Medicine)

Pooled Sputum Testing Offers Lower-Cost Molecular Diagnosis for Tuberculosis

New data show pooled sputum testing halves cartridges and costs for rapid TB diagnosis. Read more
08 Oct 2026 | Molecular Diagnostics

Image: The findings indicate that measuring Lp(a) may help identify individuals at increased lifetime risk of atherosclerosis beyond conventional cardiovascular risk factors. (Image Credit: Adobe Stock)

Elevated Lipoprotein(a) Linked to Long-Term Progression of Carotid Atherosclerosis

New findings link elevated Lp(a) to carotid plaque, faster artery wall thickening, and higher stenosis risk. Read more
08 Oct 2026 | Clinical Chem.

Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

A new urine test rapidly detects Aspergillus antigens, enabling faster, noninvasive diagnosis of invasive aspergillosis. Read more
08 Oct 2026 | Microbiology

Image: The treatment approach combines taxane chemotherapy with trastuzumab and pertuzumab for 12 weeks before surgery. Patients achieving pCR receive no further chemotherapy and continue dual HER2 blockade for one year (Image Credit: Shutterstock)

Tumor Markers Help Predict Response to Less Intensive HER2+ Chemotherapy

Tumor markers and molecular testing predict complete response to shorter therapy in HER2-positive breast cancer. Read more
07 Oct 2026 | Molecular Diagnostics

Expanded Sequencing Panel Supports Myeloid Malignancy Variant Profiling

Pillar Biosciences has launched the RUO oncoReveal Myeloid v2 NGS Panel, expanding coverage for myeloid malignancies from 58 to 80 gene targets. Read more
07 Oct 2026 | Molecular Diagnostics

.Image: Paradigm for the diagnosis of Primary mitochondrial disorders (Johan L K Van Hove et al. EMBO Molecular Medicine, 2026. https://doi.org/10.1038/s44321-026-00497-3)

Functional Testing From Skin Biopsy Improves Detection of Mitochondrial Disease

Functional testing of skin-derived fibroblasts improves primary mitochondrial disease diagnosis and reduces invasive biopsies. Read more
07 Oct 2026 | Molecular Diagnostics

Image: As the Bundibugyo Ebola outbreak continues in the DRC, testing demand is exceeding laboratory capacity, underscoring the need for public-private partnerships to strengthen the response (Image Credit: 123RF)

New Molecular Testing Support to Strengthen Ebola Surveillance in DRC

New lab instruments support local validation of Ebola PCR, boosting case detection and surveillance capacity. Read more
07 Oct 2026 | Molecular Diagnostics

Image: Dr. Gavin Arno (left) and Dr. Richard Steet in the research laboratory at the Greenwood Genetic Center (Photo courtesy of Greenwood Genetic Center)

Genetic Study Links Inherited Blindness to Gene Tied to Rare Metabolic Disorder

New findings link genetic variants to retinitis pigmentosa without broader metabolic disease signs. Read more
07 Oct 2026 | BioResearch

Image: A new Manchester study is investigating whether breast milk could help detect breast cancer earlier than blood tests or scans, particularly in women who develop the disease during or shortly after pregnancy. (Photo courtesy of The University of Manchester)

Breast Milk DNA Test Investigated for Early Breast Cancer Detection

Breast milk could signal breast cancer during or shortly after pregnancy earlier than blood tests or imaging. Read more
07 Oct 2026 | Molecular Diagnostics

Image: Guardant Reveal is a tissue-free liquid biopsy test that detects MRD and monitors recurrence in early-stage colorectal, breast, and lung cancers to help guide treatment decisions (Photo courtesy of Guardant Health)

Blood-Based MRD Test Predicts Recurrence Risk After Melanoma Surgery

A tissue-free liquid biopsy detects ctDNA MRD to predict melanoma recurrence earlier, with 81% sensitivity and 100% specificity. Read more
07 Oct 2026 | Molecular Diagnostics

Image: The red, peach-flavored candy coating on Lollylab stimulates saliva production, and a sensor at the bottom analyzes it for acetaminophen. (Image Credit: Adapted from ACS Sensors 2026, DOI: 10.1021/acssensors.6c00691)

Lollipop-Inspired Device Measures Acetaminophen Levels in Saliva

The “Lollylab” rapidly measures acetaminophen levels in saliva in under two minutes. Read more
06 Oct 2026 | Clinical Chem.

$Image: Curve Biosciences’ Whole-Body Intelligence platform uses AI and the company\'s Whole-Body Atlas to uncover organ-specific biology from blood (photo courtesy of Curve Biosciences)$

Blood Test Detects Molecular Signals of Early Liver Cancer Progression

A new blood test shows potential to monitor liver disease and detect very early HCC with 77.8% sensitivity, 81.5% specificity. Read more
06 Oct 2026 | Molecular Diagnostics

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

New findings on fetal DNA biology aim to increase fetal DNA levels in maternal blood and improve prenatal screening accuracy.

Channels

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

$Image: Andrew Terentis, Ph.D., senior author, professor and chair of Florida Atlantic\'s Department of Chemistry and Biochemistry. (Image Credit: Florida Atlantic University)$

Noninvasive AI-Enabled Raman Probe Distinguishes Skin Cancers from Normal Tissue

Skin cancer is the most common cancer in the United States and among the most common worldwide. Nearly 1.5 million new cases were diagnosed globally in 2024, including nearly 340,000 melanomas.... Read more

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Image:Geographic distribution of the survey respondents. (Cavalier E, Kapoula G, Bhattoa HP, et al. IOF-IFCC international survey of global laboratory practices for bone status indices. Clin Chem Lab Med. 2026. DOI:10.1515/cclm-2026-0941.)

Global Survey Underscores Need to Standardize Bone Biomarker Testing

Bone and mineral metabolism biomarkers can complement dual-energy X-ray absorptiometry (DXA) by providing information on disease activity and treatment response. For more than 20 years, standardization... Read more

Blood-Based MRD Test Shows High Specificity in Colorectal Cancer Trials

Patients with stage II and III colorectal cancer may require monitoring for residual or recurrent disease after treatment. Circulating tumor DNA (ctDNA) testing offers a blood-based way to detect remaining... Read more

Facilitated Cascade Program Increases Genetic Testing in Hereditary Cancer Families

Hereditary cancer risk can extend beyond an individual patient to parents, siblings, and children. Although BRCA1 and BRCA2 mutations are linked to elevated risks of breast, ovarian, prostate, and other... Read more

Image: The test measures tumor-derived RNA in urine, capturing not only the presence of cancer but also which genes the tumor is actively using. (Image Credit: Shutterstock)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive

Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

$Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)$